Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skopinpharm is a prominent Russian pharmaceutical company focused on the manufacturing of complex medicines for oncology, hematology, and rare diseases. Located in the Ryazan region, the company operates a state-of-the-art GMP-certified production complex that offers full-cycle manufacturing and secondary packaging services. Skopinpharm serves as a strategic partner for international pharmaceutical corporations, facilitating the localization of innovative therapies within the Russian market. Their portfolio includes critical treatments such as blood coagulation factors and enzyme replacement therapies for Gaucher disease. The company plays a vital role in the Russian healthcare system by ensuring the availability of high-tech orphan drugs through its collaboration with major distributors like Pharmimex.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skopinpharm.